All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The Consejo Superior de Investigaciones Cientificas (CSIC) has identified chemokine CXCR4 (SDF-1 receptor) receptor ligands reported to be useful for the treatment of cancer, rheumatoid arthritis and AIDS.
